Design Therapeutics, Inc. Common Stock (DSGN) is a publicly traded Healthcare sector company. As of October 2, 2026, DSGN trades at $12.74 with a market cap of $786.65M and a P/E ratio of -10.32. DSGN moved +4.09% today. Year to date, DSGN is +34.51%; over the trailing twelve months it is +80.27%. Its 52-week range spans $2.60 to $17.25. Analyst consensus is strong buy with an average price target of $27.51. Rallies surfaces DSGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks DSGN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $12.74 |
| Market Cap | $786.65M |
| P/E Ratio | -10.32 |
| EPS | $-1.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.25 |
| 52-Week Low | $2.60 |
| Volume | 1.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-69.79M |
| Gross Margin | 0.00% |
3 analysts cover DSGN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.51.